vs
Aptorum Group Ltd（APM）与908 Devices Inc.（MASS）财务数据对比。点击上方公司名可切换其他公司
908 Devices Inc.的季度营收约是Aptorum Group Ltd的39.2倍（$17.4M vs $442.8K）。908 Devices Inc.净利率更高（24.0% vs -63.8%，领先87.8%）
Aptorum Group Ltd是一家跨国生物制药企业，专注于传染病、女性健康相关疾病和罕见病领域的创新治疗及诊断方案的研发、生产与商业化，核心运营市场覆盖北美及亚太多个国家和地区。
908 Devices Inc.是一家专注于研发、生产高性能便携式质谱分析设备及相关解决方案的科技企业，产品覆盖生命科学研究、生物制药制造、公共安全、法医鉴定、工业过程监测等领域，服务全球科研机构、制药企业及政府部门客户。
APM vs MASS — 直观对比
营收规模更大
MASS
是对方的39.2倍
$442.8K
净利率更高
MASS
高出87.8%
-63.8%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $442.8K | $17.4M |
| 净利润 | $-282.5K | $4.2M |
| 毛利率 | — | 52.7% |
| 营业利润率 | -52.6% | 17.8% |
| 净利率 | -63.8% | 24.0% |
| 营收同比 | — | 21.2% |
| 净利润同比 | — | 121.5% |
| 每股收益（稀释后） | $-0.04 | $0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APMMASS
| Q4 25 | $442.8K | $17.4M | ||
| Q3 25 | $208.8K | $14.0M | ||
| Q2 25 | — | $13.0M | ||
| Q1 25 | — | $11.8M | ||
| Q4 24 | — | $14.3M | ||
| Q3 24 | — | $14.5M | ||
| Q2 24 | — | $11.5M | ||
| Q1 24 | — | $7.4M |
净利润APMMASS
| Q4 25 | $-282.5K | $4.2M | ||
| Q3 25 | $-614.0K | $-15.0M | ||
| Q2 25 | — | $-13.3M | ||
| Q1 25 | — | $43.6M | ||
| Q4 24 | — | $-19.4M | ||
| Q3 24 | — | $-29.3M | ||
| Q2 24 | — | $-12.5M | ||
| Q1 24 | — | $-10.9M |
毛利率APMMASS
| Q4 25 | — | 52.7% | ||
| Q3 25 | — | 52.5% | ||
| Q2 25 | — | 48.9% | ||
| Q1 25 | — | 47.0% | ||
| Q4 24 | — | 46.5% | ||
| Q3 24 | — | 53.6% | ||
| Q2 24 | — | 53.8% | ||
| Q1 24 | — | 52.4% |
营业利润率APMMASS
| Q4 25 | -52.6% | 17.8% | ||
| Q3 25 | -71.9% | -116.6% | ||
| Q2 25 | — | -116.3% | ||
| Q1 25 | — | -93.6% | ||
| Q4 24 | — | -116.8% | ||
| Q3 24 | — | -168.7% | ||
| Q2 24 | — | -74.5% | ||
| Q1 24 | — | -102.5% |
净利率APMMASS
| Q4 25 | -63.8% | 24.0% | ||
| Q3 25 | -294.0% | -107.0% | ||
| Q2 25 | — | -102.1% | ||
| Q1 25 | — | 370.2% | ||
| Q4 24 | — | -135.6% | ||
| Q3 24 | — | -201.8% | ||
| Q2 24 | — | -109.5% | ||
| Q1 24 | — | -147.1% |
每股收益（稀释后）APMMASS
| Q4 25 | $-0.04 | $0.09 | ||
| Q3 25 | $-0.09 | $-0.41 | ||
| Q2 25 | — | $-0.37 | ||
| Q1 25 | — | $1.23 | ||
| Q4 24 | — | $-0.58 | ||
| Q3 24 | — | $-0.84 | ||
| Q2 24 | — | $-0.37 | ||
| Q1 24 | — | $-0.33 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.5M | $113.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $23.1M | $143.7M |
| 总资产 | $18.7M | $190.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资APMMASS
| Q4 25 | $3.5M | $113.0M | ||
| Q3 25 | $56.8K | $112.1M | ||
| Q2 25 | — | $118.6M | ||
| Q1 25 | — | $124.3M | ||
| Q4 24 | — | $69.6M | ||
| Q3 24 | — | $71.7M | ||
| Q2 24 | — | $77.4M | ||
| Q1 24 | — | $134.2M |
股东权益APMMASS
| Q4 25 | $23.1M | $143.7M | ||
| Q3 25 | $22.5M | $136.3M | ||
| Q2 25 | — | $148.8M | ||
| Q1 25 | — | $159.4M | ||
| Q4 24 | — | $114.6M | ||
| Q3 24 | — | $131.0M | ||
| Q2 24 | — | $156.4M | ||
| Q1 24 | — | $156.9M |
总资产APMMASS
| Q4 25 | $18.7M | $190.1M | ||
| Q3 25 | $17.6M | $190.9M | ||
| Q2 25 | — | $191.7M | ||
| Q1 25 | — | $196.0M | ||
| Q4 24 | — | $159.5M | ||
| Q3 24 | — | $178.3M | ||
| Q2 24 | — | $208.8M | ||
| Q1 24 | — | $189.8M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-145.9K | $1.3M |
| 自由现金流经营现金流 - 资本支出 | — | $1.3M |
| 自由现金流率自由现金流/营收 | — | 7.6% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | 0.32× |
| 过去12个月自由现金流最近4个季度 | — | $-24.7M |
8季度趋势，按日历期对齐
经营现金流APMMASS
| Q4 25 | $-145.9K | $1.3M | ||
| Q3 25 | $-484.3K | $-4.2M | ||
| Q2 25 | — | $-5.8M | ||
| Q1 25 | — | $-15.0M | ||
| Q4 24 | — | $-2.2M | ||
| Q3 24 | — | $-5.6M | ||
| Q2 24 | — | $-13.0M | ||
| Q1 24 | — | $-9.4M |
自由现金流APMMASS
| Q4 25 | — | $1.3M | ||
| Q3 25 | — | $-4.9M | ||
| Q2 25 | — | $-5.9M | ||
| Q1 25 | — | $-15.2M | ||
| Q4 24 | — | $-2.4M | ||
| Q3 24 | — | $-5.8M | ||
| Q2 24 | — | $-13.7M | ||
| Q1 24 | — | $-10.3M |
自由现金流率APMMASS
| Q4 25 | — | 7.6% | ||
| Q3 25 | — | -34.9% | ||
| Q2 25 | — | -45.3% | ||
| Q1 25 | — | -128.9% | ||
| Q4 24 | — | -17.0% | ||
| Q3 24 | — | -39.7% | ||
| Q2 24 | — | -119.4% | ||
| Q1 24 | — | -138.2% |
资本支出强度APMMASS
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 4.9% | ||
| Q2 25 | — | 0.9% | ||
| Q1 25 | — | 1.4% | ||
| Q4 24 | — | 1.3% | ||
| Q3 24 | — | 1.1% | ||
| Q2 24 | — | 5.6% | ||
| Q1 24 | — | 12.2% |
现金转化率APMMASS
| Q4 25 | — | 0.32× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -0.34× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APM
暂无分部数据
MASS
| Products | $14.3M | 82% |
| Services | $3.0M | 18% |
